Abstract
Glioblastoma multiforme is the most aggressive type of glioma, with
limited treatment and poor prognosis. Despite some advances over the
last decade, validation of novel and selective antiglioma agents remains
a challenge in clinical pharmacology. Prior studies have shown that
leguminous lectins may exert various biological effects, including
antitumor properties. Accordingly, this study aimed to evaluate the
mechanisms underlying the antiglioma activity of ConBr, a lectin
extracted from the Canavalia brasiliensis seeds. ConBr at lower
concentrations inhibited C6 glioma cell migration while higher levels
promoted cell death dependent upon carbohydrate recognition domain (CRD)
structure. ConBr increased p38(MARK) and JNK and decreased ERK1/2 and
Akt phosphorylation. Moreover, ConBr inhibited mTORC1 phosphorylation
associated with accumulation of autophagic markers, such as acidic
vacuoles and LC3 cleavage. Inhibition of early steps of autophagy with
3-methyl-adenine (3-MA) partially protected whereas the later(
)autophagy inhibitor Chloroquine (CQ) had no protective effect upon
ConBr cytotoxicity. ConBr also augmented caspase-3 activation without
affecting mitochondrial function. Noteworthy, the caspase-8 inhibitor
IETF-fmk attenuated ConBr induced autophagy and C6 glioma cell death.
Finally, ConBr did not show cytotoxicity against primary astrocytes,
suggesting a selective antiglioma activity. In summary, our results
indicate that ConBr requires functional CRD lectin domain to exert
anti-glioma activity, and its cytotoxicity is associated with MAPKs and
Akt pathways modulation and autophagy- and caspase-8- dependent cell
death. (C) 2020 Elsevier B.V. and Societe Francaise de Biochimie et
Biologie Moleculaire (SFBBM). All rights reserved.
Users
Please
log in to take part in the discussion (add own reviews or comments).